RS Communication Overview
RS Communication is a premier communication agency based in Belgium, specifically located in the beautiful town of Grimbergen. Established in 2002, RS Communication has been a pioneer in the world of ... Read More
$2 – $9 number of employees
$25/hr - $49/hr hourly rate
$20,000 - $29,999 minimal budget
2002 year founded
Services
8 services offered by RS Communication
Advertising
Copywriting
Video Production
Digital Marketing
Online Advertising
Animation
Infographic Design
Graphic IdentityReviews
0 reviews for RS CommunicationPortfolio
5 projects performed by RS Communication
Tiorfix is a cutting-edge advertising project that aims to revolutionize the way businesses promote their products and services. With a team of experts in marketing and technology, Tiorfix offers innovative solutions to help companies reach their target audience effectively.
Pantomed Campagne is an advertising project aimed at promoting the benefits and uses of Pantomed products. Through strategic marketing campaigns and targeted advertising, the project seeks to increase brand awareness and drive sales for Pantomed products.
Entyvio is a biologic medication used to treat adults with moderate to severe ulcerative colitis and Crohn's disease. It works by specifically targeting and blocking certain proteins that cause inflammation in the digestive tract.
Riopan is an advertising project that focuses on creating innovative and eye-catching campaigns for various clients. With a team of creative professionals, we strive to deliver unique and impactful advertising solutions that help our clients stand out in a crowded market.
The Capsugel Coni-Snap sprinkle project is a innovative solution for delivering medication in a convenient and easy-to-use capsule form. The sprinkle capsules are designed to easily open and sprinkle the contents onto food or into beverages, making it ideal for patients who have difficulty swallowing pills.
Entyvio
by RS CommunicationDescription
Entyvio is a biologic medication used to treat adults with moderate to severe ulcerative colitis and Crohn's disease. It works by specifically targeting and blocking certain proteins that cause inflammation in the digestive tract.
Challenge
One of the main challenges in treating inflammatory bowel diseases like ulcerative colitis and Crohn's disease is finding a medication that effectively reduces inflammation without causing severe side effects. Many patients struggle to find relief from their symptoms with traditional treatments.
Solution
Entyvio provides a targeted approach to treating ulcerative colitis and Crohn's disease by specifically blocking inflammatory proteins in the digestive tract. This helps reduce inflammation and alleviate symptoms without affecting the entire immune system, leading to a more targeted and effective treatment option for patients.
Impact
By providing a more targeted and effective treatment option for patients with ulcerative colitis and Crohn's disease, Entyvio has the potential to improve quality of life and reduce disease progression. Many patients who have tried other treatments without success have found relief with Entyvio, leading to better symptom management and overall well-being.